This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Sources: Australasian College of Pharmacy. Management of reflux: a guideline for pharmacists. Queensland Health. Queensland Community Pharmacy Gastro-oesophageal Reflux and Gastro-oesophageal Reflux Disease – Clinical Practice Guideline. NSW Health. NSW Pharmacist Practice Standards for gastro-oesophageal reflux and gastro-oesophageal reflux disease.[/caption]
Dr Ming S Soh PhD, BPharm (Hons)[/caption]
DR Amy Page (she/her) PhD, MClinPharm, GradDipBiostat, GCertHProfEd, GAICD, GStat, FSHPA, FPS is a consultant pharmacist, biostatistician, and the director of the Centre for Optimisation of Medicines at UWA’s School of Allied Health.[/caption]
Hui Wen Quek (she/her) BPharm(Hons), GradCertAppPharmPrac is a pharmacist and PhD candidate at the University of Western Australia (UWA).[/caption]
Case scenario
A regular patient enters the pharmacy early one morning. You recognise her, but something is different. Her face is pale and drawn, her expression distracted and troubled. You notice a slight tremor in her hand as she reaches for a tube of heparinoid cream. When she sees you approaching, she withdraws into a corner and avoids eye contact.
Choosing to keep a respectful distance, you observe discreetly as she moves through the pharmacy, collecting paracetamol and bandages. Her behaviour raises concern. This does not appear to be a typical encounter, and you begin to wonder whether something more serious might be going on.
Learning objectivesAfter reading this article, pharmacists should be able to:
|
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
